Akso Health Group

NASDAQ: HX · Real-Time Price · USD
2.24
-0.10 (-4.27%)
At close: Dec 16, 2021, 6:00 AM

Akso Health Income Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2021
Period Ending Mar 31, 2021
Revenue
1.75M
Cost of Revenue
544.57K
Gross Profit
1.21M
Operating Income
-27.15M
Interest Income
n/a
Pretax Income
-31.07M
Net Income
-34.83M
Selling & General & Admin
28.36M
Research & Development
n/a
Other Expenses
n/a
Operating Expenses
28.36M
Interest Expense
2.15M
Selling & Marketing Expenses
1.09M
Cost & Expenses
28.9M
Income Tax Expense
482.98K
Shares Outstanding (Basic)
16.25M
Shares Outstanding (Diluted)
16.25M
EPS (Basic)
-2.14
EPS (Diluted)
-2.14
EBITDA
-32.17M
EBIT
-28.91M
Depreciation & Amortization
15.16K